Histamine H2 blocking drugs and the risk for Alzheimer's disease: The Rotterdam Study

Neurobiology of Aging

Volumn 18, Issue 2, 1997, Pages 257-259

  Launer, L J ^a,b   Jama, J Warsama ^a,b   Ott, A ^a,b   Breteler, M M B ^a,b   Hoes, A W ^a,b   Hofman, A ^a,b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Netherlands Institute for Health Sciences   (Netherlands)

Author keywords

AIzheimer's disease; Epidemiology; Histamine H2 blockers; Inflammatory processes

Indexed keywords

BENZODIAZEPINE DERIVATIVE; HISTAMINE H2 RECEPTOR ANTAGONIST; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DRUG USE; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; NEUROPROTECTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

AGED; ALZHEIMER DISEASE; CROSS-SECTIONAL STUDIES; DATA INTERPRETATION, STATISTICAL; FEMALE; HISTAMINE H2 ANTAGONISTS; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; RISK;

EID: 0030872658     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(97)00010-9     Document Type: Article

References (14)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 3rd ed. Washington, DC: American Psychiatric Association; 1987.
2. Andersen K.; Launer, L. J.; Ott, A.; Hoes, A. W.; Breteler, M. M. B.; Hofman, A. Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer's Disease? The Rotterdam Study. Neurology 45:1441-1445; 1995.
3. Anonymous. Guidelines for ATC classification. Oslo: WHO Collaborating Centre for Drug Statistics Methodology - Nordic Council on Medicines; 1990.
4. Breitner J. C. S.; Welsch, K. A.; Helms, M. J.; Gaskell, P. C.; Gau, B. A.; Roses, A. D.; Pericak-Vance, M. A.; Saunders, A. Delayed onset of Alzheimer's disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs. Neurobiol. Aging 16:523-530; 1995.
5. Copeland, J. R. M.; Keleher, M. R.; Kellet, J. M.; Grourlay, A. J.; Gurland, B. J.; Fleiss, J. L.; Sharpe L. A semi-structured clinical interview for the assessment of diagnosis and mental state in the elderly. The geriatric mental state schedule. I. Development and reliability. Psychol. Med. 6:439-449; 1976.
6. Dixon, W. J.; Brown, M. B.; Engelman, L.; Jennrich, R. I. BMDP statistical software manual. Los Angeles, CA: University of California Press; 1990.
7. Dugan, L. L.; Choi, D. W. Excitotoxicity, free radicals and cell membrane changes. Ann. Neurol. 35:S17-S21; 1994.
8. Folstein, M. F.; Folstein, S. E.; McHugh, P. R. "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12:189-198; 1975.
9. Hoes, A. W.; Grobbee, D. E.; Lubsen, J. Primary prevention in hypertension. Valid conclusions from observational studies. Circulation 84(Suppl. 4):VI78-83; 1991.
10. Hofman, A.; Grobbee, D. E.; de Jong, P. T. V. M.; van den Ouweland, F. A. Determinants of disease and disability in the elderly: The Rotterdam Elderly study. Eur. J. Epidemiol. 7:403-422; 1991.
11. McKahnn, G.; Drachman, D.; Folstein, M.; Katzman, R.; Price, D.; Stadlan, E. M. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34:939-944; 1984.
12. Miettenen, O. The need for randomization in the study of unintended effects. Stat. Med. 2:267-271; 1983.
13. Ott, A.; Breteler, M. M. B.; van Harskamp, F.; Claus, J. J.; van der Cammen, T. J. M.; Grobbee, D. E.; Hofman, A. Prevalence of Alzheimer's disease and vascular dementia: Association with education. The Rotterdam Study. Br. Med. J. 310:970-973; 1995.
14. Roth, M.; Hubbert, F.; Tym, E.; Mountjoy, C. Q. CAMDEX: A standardized instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br. J. Psychiatry 149:698-709; 1986.